Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-05-01T05:43:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T14:45:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated to a new version (v2.14.4) as of April 2, 2025, replacing the previous version (v2.14.3) from March 25, 2025).
    Difference
    1.0%
    Check dated 2025-04-09T10:13:48.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T22:15:33.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page has updated the treatment options for Acute Myeloid Leukemia and Myelodysplastic Syndrome, changing the relevant date from October 28, 2024, to February 10, 2025.
    Difference
    0.9%
    Check dated 2025-02-17T18:01:40.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T14:47:47.000Z thumbnail image

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.